Preprint Hypothesis Version 1 Preserved in Portico This version is not peer-reviewed

Is the Electrohypersensitive Patient's Headache a Variant of the Migraine Disease Mediated by TRPA1 Receptors?

Version 1 : Received: 23 September 2020 / Approved: 24 September 2020 / Online: 24 September 2020 (18:22:45 CEST)

How to cite: Greco, F. Is the Electrohypersensitive Patient's Headache a Variant of the Migraine Disease Mediated by TRPA1 Receptors?. Preprints 2020, 2020090588 (doi: 10.20944/preprints202009.0588.v1). Greco, F. Is the Electrohypersensitive Patient's Headache a Variant of the Migraine Disease Mediated by TRPA1 Receptors?. Preprints 2020, 2020090588 (doi: 10.20944/preprints202009.0588.v1).

Abstract

According to the French Agency for Food, Environmental and Occupational Health & Safety, electromagnetic hypersensitivity affects more than 3 million people in France, and headaches are a very frequent cause of complaint in electrohypersensitive patients, to the point of dominating the clinical picture. These headaches share characteristics with migraine pathology, and clinical improvement with anti-migraine therapy has led us to consider that the headache in the electrohypersensitive patient may be a variant of the migraine disease mediated by the TRPA1 receptor, which if confirmed, would offer effective therapeutic possibilities to relieve the electrohypersensitive patient.

Subject Areas

electromagnetic hypersensitivity; multiple chemical sensitivity; migraine; TRPA1

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.